Source: Annual Congress 2006 - Community-acquired pneumonia: risk factors and treatment
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
O. V. Fessenko (Moscow, Russian Federation). Recognising poor prognosis community-acquired pneumonia in young adults with simple clinical measurements. Eur Respir J 2006; 28: Suppl. 50, 2093

Member's Comments

No comment yet.

Related content which might interest you: Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002 Etiology and clinical outcome of community-acquired pneumonias in hospitalized children Source: Eur Respir J 2007; 30: Suppl. 51, 398s Year: 2007 Another view on the prediction of outcomes in patients with community-acquired pneumonia Source: Eur Respir J 2011; 38: 991-992 Year: 2011 Another view on the prediction of outcomes in patients with community-acquired pneumonia Source: Eur Respir J 2011; 38: 992-993 Year: 2011 Evaluation of different predictive rules in young adults died from community-acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 Determinants of community-acquired pneumonia in children and young adults in primary care Source: Eur Respir J 2010; 35: 1113-1117 Year: 2010 Female gender is associated with poor clinical outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Community-acquired pneumonia in the elderly: Spanish multicentre study Source: Eur Respir J 2003; 21: 294-302 Year: 2003 Thrombocytosis predicts poor outcomes in patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Thrombocytosis is a marker of poor outcome in community-acquired pneumonia Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Community-acquired pneumonia in the elderly Source: Eur Respir Mon; 2009: 43: 111–132 Year: 2009 The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007 Community-acquired pneumonia in COVID-19 positive children: monitoring the clinical course Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021 Clinical features of COVID-19 pneumonia in elderly patients Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Pleural effusion predicts poor outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 Prediction of complications development and lethal outcome in patients with community-acquired pneumonia Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged >=75 yrs Source: Eur Respir J 2001; 17: 200-205 Year: 2001 Difficult diagnosis of severe community acquired pneumonia in young people Source: Annual Congress 2009 - Pulmonary infections Year: 2009 Obesity is associated with improved outcome in community-acquired pneumonia Source: Annual Congress 2012 - Prognosis and outcome of respiratory infections Year: 2012